Outcomes of Pediatric SARS-CoV-2 Omicron Infection vs Influenza and Respiratory Syncytial Virus Infections

Pontus Hedberg; Lina Abdel-Halim; John Karlsson Valik; Tobias Alfvén; Pontus Nauclér

doi:10.1001/jamapediatrics.2023.5734

Outcomes of Pediatric SARS-CoV-2 Omicron Infection vs Influenza and Respiratory Syncytial Virus Infections

JAMA Pediatr. 2024 Feb 1;178(2):197-199. doi: 10.1001/jamapediatrics.2023.5734.

Authors

Pontus Hedberg¹, Lina Abdel-Halim², John Karlsson Valik², Tobias Alfvén³, Pontus Nauclér⁴

Affiliations

¹ Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
² Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
⁴ Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Plain language summary

This cohort study compares outcomes of SARS-CoV-2 Omicron infection with those of influenza or respiratory syncytial virus infection in pediatric patients attending the emergency department.

MeSH terms

COVID-19*
Child
Humans
Influenza, Human*
Respiratory Syncytial Virus Infections*
Respiratory Tract Infections*
SARS-CoV-2